Publications by authors named "Norman Peter"

Claim this Profile
T
The lived experience of depression: a bottom-up review co-written by experts by experience and academics.
Paolo Fusar-Poli, Andrés Estradé, Giovanni Stanghellini, Cecilia Maria Esposito, René Rosfort, Peter Norman

World Psychiatry· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Ventilatory Strategy to Prevent Atelectasis During Bronchoscopy Under General Anesthesia: A Multicenter Randomized Controlled Trial (Ventilatory Strategy to Prevent Atelectasis -VESPA- Trial).
Moiz Salahuddin, Mona Sarkiss, Ala-Eddin S Sagar, Ioannis Vlahos, Christopher H Chang, Peter H Norman

Chest· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inclusion of Anesthesiologists and Surgeons While Developing Guidelines for Management of Immune-Related Adverse Events.
Peter H Norman, Teresa Moon Calderon, Yinghong Wang, Ashish M Kamat

J Immunother Precis Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brexit and UK market exclusivities.
Peter Norman

Pharm Pat Anal· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humira: recent developments.
Peter Norman

Pharm Pat Anal· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enbrel and etanercept biosimilars: a tale of two patent systems.
Peter Norman

Pharm Pat Anal· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigational Bruton's tyrosine kinase inhibitors for the treatment of rheumatoid arthritis.
Peter Norman

Expert Opin Investig Drugs· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developments in inhaled combination therapies: patent activity 2013-2014.
Peter Norman

Expert Opin Ther Pat· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humira: the impending patent battles over adalimumab biosimilars.
Peter Norman

Pharm Pat Anal· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of US20150011555. An inhaled IP receptor agonist for the treatment of pulmonary arterial hypertension.
Peter Norman

Expert Opin Ther Pat· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A political thought on the "Friday effect".
Peter H Norman

Can J Anaesth· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of WO-2014132220, selective PDGFR inhibitors for the treatment of pulmonary arterial hypertension.
Peter Norman

Expert Opin Ther Pat· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease.
Peter Norman

Expert Opin Investig Drugs· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respivert's multikinase inhibitors, an evaluation of WO2014033446 to WO2014033449.
Peter Norman

Expert Opin Ther Pat· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complications associated with the prehospital use of laryngeal tubes--a systematic analysis of risk factors and strategies for prevention.
Richard Schalk, Florian H Seeger, Haitham Mutlak, Uwe Schweigkofler, Kai Zacharowski, Norman Peter

Resuscitation· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of WO2014075392 and WO2014075393, Merck's first PI3Kδ inhibitor filings.
Peter Norman

Expert Opin Ther Pat· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inducible tyrosine kinase inhibitors: a review of the patent literature (2010 - 2013).
Peter Norman

Expert Opin Ther Pat· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective evaluation of the use of video-capable double-lumen endotracheal tubes in thoracic surgery.
Jagtar Singh Heir, Ron Purugganan, Timothy A Jackson, Peter H Norman, Juan P Cata

J Cardiothorac Vasc Anesth· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection.
Juan P Cata, Visesh Keerty, Dinesh Keerty, Lei Feng, Peter H Norman

Cancer Med· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of salt-inducible kinase inhibitors to treat autoimmune and inflammatory diseases: evaluation of WO2013136070.
Peter Norman

Expert Opin Ther Pat· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective JAK inhibitors in development for rheumatoid arthritis.
Peter Norman

Expert Opin Investig Drugs· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel picolinamide-based cystic fibrosis transmembrane regulator modulators: evaluation of WO2013038373, WO2013038376, WO2013038381, WO2013038386 and WO2013038390.
Peter Norman

Expert Opin Ther Pat· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of WO2013117503 and WO2013117504: the use of PI3K inhibitors to treat cough or idiopathic pulmonary fibrosis.
Peter Norman

Expert Opin Ther Pat· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of WO2013116562A, an orally active PI3Kδ inhibitor for the treatment of asthma.
Peter Norman

Expert Opin Ther Pat· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spleen tyrosine kinase inhibitors: a review of the patent literature 2010 - 2013.
Peter Norman

Expert Opin Ther Pat· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis